scispace - formally typeset
N

Nora D. Volkow

Researcher at National Institute on Drug Abuse

Publications -  1038
Citations -  121498

Nora D. Volkow is an academic researcher from National Institute on Drug Abuse. The author has contributed to research in topics: Dopamine & Addiction. The author has an hindex of 165, co-authored 958 publications receiving 107463 citations. Previous affiliations of Nora D. Volkow include National Institutes of Health & North Shore University Hospital.

Papers
More filters
Journal ArticleDOI

Functional connectivity density mapping

TL;DR: A 103 times faster method to map the distribution of the local functional connectivity density (lFCD) in the human brain is proposed and it is suggested that that brain networks have a “scale-free” organization.
Journal ArticleDOI

Evaluating Dopamine Reward Pathway in ADHD: Clinical Implications

TL;DR: A reduction in dopamine synaptic markers associated with symptoms of inattention was shown in the dopamine reward pathway of participants with ADHD.
Journal ArticleDOI

Drug addiction: the neurobiology of disrupted self-control

TL;DR: It is posit that the time has come to recognize that the process of addiction erodes the same neural scaffolds that enable self-control and appropriate decision making and should attempt to reduce the rewarding properties of drugs while enhancing those of alternative reinforcers, inhibit conditioned memories and strengthen cognitive control.
Journal ArticleDOI

Aging and functional brain networks

TL;DR: It is suggested that long-range connections may be more vulnerable to aging effects than short- range connections and that, in addition to the DMN, the DAN is also sensitive to Aging effects, which could underlie the deterioration of attention processes that occurs with aging.
Journal ArticleDOI

Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors.

TL;DR: Assessment of the relationship between dopamine D2 receptor availability in striatum with brain glucose metabolism in obese subjects and controls suggested that decreases in striatal D2 receptors could contribute to overeating via their modulation of striatal prefrontal pathways, which participate in inhibitory control and salience attribution.